دورية أكاديمية

862P - Retrospective evaluation of neutropenic admission events in metastatic or high-risk hormone-sensitive prostate cancer (HSPC) patients having docetaxel chemotherapy upfront or for castrate-resistant prostate cancer (CRPC) in STAMPEDE

التفاصيل البيبلوغرافية
العنوان: 862P - Retrospective evaluation of neutropenic admission events in metastatic or high-risk hormone-sensitive prostate cancer (HSPC) patients having docetaxel chemotherapy upfront or for castrate-resistant prostate cancer (CRPC) in STAMPEDE
المؤلفون: Mintz, H.P., Amos, C., Brannan, R., Brawley, C., Calvert, J., Gannon, M.R., Hounsome, L., Ingleby, F.C., McPhail, S., Parmar, M.K.B., Parsons, H.M., Patel, P., Rauchenberger, M., Sydes, M.R., Wu, H., James, N.D.
المصدر: In Annals of Oncology October 2019 30 Supplement 5:v337-v337
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdz248.019